ción del eje hipotálamo-hipofisario. 2. Que hay casos de rinitis
alérgica estacional o no alérgica que se asocian a fibromial-
gia
112
. Precisamente el estudio de Cleveland y cols.
112
demos-
tró que la prevalencia de la fibromialgia en pacientes con rini-
tis era muy superior a la esperada en la población general ya
que mientras en ésta es del 4-5%, en los casos de rinitis estu-
diados demostraron que el 38% presentaban historia de
dolor difuso además de 11 o más puntos dolorosos que es
uno de los criterios que el
American College of Reumatho-
logy
institucionalizó en 1990 como hecho necesario para el
diagnóstico de fibromialgia. Y aún hay algo más, Bellanti y
cols.
113
en 2005 insistieron en el papel de la alergia, especial-
mente a alimentos o sus componentes, como disparadores
del cuadro fisiopatológico del síndrome de la fatiga crónica y
de la fibromialgia. Todo esto habrá que comprobarlo en un
futuro inmediato.
Lo que sí está claro, y así lo hemos señalados desde el prin-
cipio, es que la histamina produce contracción del músculo
liso (fig. 1) y que, como síntoma directo sobre el sistema
musculoesquelético, podríamos comprobar calambres mus-
culares; sin embargo, hoy se piensa, y en ello se está investi-
gando, que habría una manifestaciones o síntomas indirectos
como dolor por presión y deshidratación de los discos inter-
vertebrales que acercarían la fibromialgia a la histaminosis
109
.
REFERENCIAS
1. Windaus A, Vogt W. Synthese des Imidazoläthylamins.
Chem
Berichte
1907; 40: 3691.
2. Chan TB, Eiser N, Shelton D, Rees PJ. Histamine receptors and pul-
monary epithelial permeability.
Br J Dis Chest
1987; 81: 260-7.
3. Pilati CF, Maron MB. Effect of histamine on coronary microvascu-
lar permeability.
Am J Physiol
1984; 247: H1-H7.
4. Bealer SL. Central Neuronal Histamine Contributes to Cardiovas-
cular Regulation.
News Physiol Sci
1999; 14: 100-5.
5. Costentin J, Boulu P, Schwartz JC. Pharmacological studies on
the role of histamine in thermoregulation.
Agents Actions
1973;
3: 177.
6. Saper CB, Lu J, Chou TC, Gooley J. The hypothalamic integrator
for circadian rhythms.
Trends Neurosci
2005; 28: 152-7.
7. Schleimer R. Regulatory roles of histamine in the immune sys-
tem.
Proc West Pharmacol Soc
1978; 21: 145-50.
8. Jutel M, Akdis M, Akdis CA. Histamine, histamine receptors and
their role in immune pathology.
Clin Exp Allergy
2009; 39:
1786-800.
9. Woodruff GN, Oniwinde AB, Kerkut GA. Histamine in tissues of
the snail, crab, goldfish, frog and mouse.
Comp Biochem Physiol
1969; 31: 599-603.
10. Kumar V, Laddu AR, Lahiri PK, Sanyal RK. The physiological levels
of histamine in human tissues.
Int Arch Allergy Appl Immunol
1968; 34: 233-6.
11. Huang JF, Thurmond RL. The new biology of histamine recep-
tors.
Curr Allergy Asthma Rep
2008; 8: 21-7.
12. Smuda C, Bryce PJ. New Developments in the Use of Histamine
and Histamine Receptors.
Curr Allergy Asthma Rep
2010.
13. Steinhoff M, Groves RW, LeBoit PE, Luger TA. Inflammation. Hista-
mine. En: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook’s Text-
book of Dermatology. Oxford, Blackwell Publ. Ltd, 2010; 12: 57-9.
14. Vlieg-Boerstra BJ, van der HS, Oude Elberink JN, Kluin-Nelemans
JC, Dubois AE. Mastocytosis and adverse reactions to biogenic
amines and histamine-releasing foods: what is the evidence?
Neth J Med
2005; 63: 244-9.
15. Kalchmair B, Klocker J, Perkmann R, et al. Alterations in plasma
amine oxidase activities in a compartment syndrome model.
Inflamm Res
2003; 52 (Suppl. 1): S67-8.
16. Wantke F, Hemmer W, Focke M, Stackl W, Gotz M, Jarisch R. Are
adverse effects of sildenafil also caused by inhibition of diamine
oxidase?
Urol Int
2001; 67: 59-61.
17. Silla Santos MH. Biogenic amines: their importance in foods.
Int J
Food Microbiol
1996; 29: 213-31.
18. Moller P, Henz BM. Histaminosis.
Dtsch Med Wochenschr
1996;
121: 885-6.
19. Barahmani N, Schabath MB, Duvic M, National Alopecia Areata
Registry. History of atopy or autoimmunity increases risk of
alopecia areata.
J Am Acad Dermatol
2009; 61: 581-91.
20. Orr E, Quay WB. Hypothalamic 24-hour rhythms in histamine,
histidine, decarboxylase and histamine-N-methyltransferase.
Endocrinology
1975; 96: 941-5.
21. Bachelet I, Levi-Schaffer F. Mast cells as effector cells: a co-stimu-
lating question.
Trends Immunol
2007; 28: 360-5.
22. Bachelet I, Levi-Schaffer F, Mekori YA. Mast cells: not only in
allergy.
Immunol Allergy Clin North Am
2006; 26: 407-25.
23. Weissler A, Mekori YA, Mor A. The role of mast cells in non-aller-
gic inflammation.
Isr Med Assoc J
2008; 10: 843-5.
24. Neutra MR, Frey A, Kraehenbuhl JP. Epithelial M cells: gateways
for mucosal infection and immunization.
Cell
1996; 86: 345-8.
25. Zivny JH, Moldoveanu Z, Vu HL, Russell MW, Mestecky J, Elson
CO. Mechanisms of immune tolerance to food antigens in
humans.
Clin Immunol
2001; 101: 158-68.
26. Maslinski C, Bielkiewicz B, Nowak JZ, Pilc A. Histamine content
and synthesis in central and pheripheral nerve structures during
stress.
Agents Actions
1975; 5: 4-8.
27. Baxter JH, Adamik R. Temperature dependence of histamine
release from rat mast cells by dextran.
Proc Soc Exp Biol Med
1974; 146: 71-4.
28. Lagunoff D, Wan H. Temperature dependence of mast cell hista-
mine secretion.
J Cell Biol
1974; 61: 809-11.
29. Maintz L, Novak N. Histamine and histamine intolerance.
Am J
Clin Nutr
2007; 85: 1185-96.
30. Petersen J, Drasche A, Raithel M, Schwelberger HG. Analysis of
genetic polymorphisms of enzymes involved in histamine
metabolism.
Inflamm Res
2003; 52 (Suppl. 1): S69-S70.
31. Sattler J, Hesterberg R, Lorenz W, Schmidt U, Crombach M,
Stahlknecht CD. Inhibition of human and canine diamine oxi-
dase by drugs used in an intensive care unit: relevance for clini-
cal side effects?
Agents Actions
1985; 16: 91-4.
32. Schmidt WU, Sattler J, Hesterberg R, Roher HD, Zoedler T, Sitter
H, Lorenz W. Human intestinal diamine oxidase (DAO) activity in
Crohn’s disease: a new marker for disease assessment?
Agents
Actions
1990; 30: 267-70.
33. Buts JP, Theys S, De KN, Dive C. Changes in serum and intestinal
diamine oxidase (DAO) activity after proximal enterectomy in
rats. Correlation of DAO activity with mucosal mass parameters.
Dig Dis Sci
1989; 34: 1393-8.
34. Fujii T. Scombroid fish poisoning due to histamine-producing
bacteria].
Shokuhin Eiseigaku Zasshi
2006; 47: J343-J348.
35. Landete JM, Ferrer S, Pardo I. Improved enzymatic method for
the rapid determination of histamine in wine.
Food Addit Con-
tam
2004; 21: 1149-54.
36. Beljaars PR, Van DR, Jonker KM, Schout LJ. Liquid chromato-
graphic determination of histamine in fish, sauerkraut, and wine:
interlaboratory study.
J AOAC Int
1998; 81: 991-8.
37. Peng JF, Fang KT, Xie DH, Ding B, Yin JY, Cui XM, Zhang Y, Liu JF.
Development of an automated on-line pre-column derivatiza-
tion procedure for sensitive determination of histamine in food
with high-performance liquid chromatography-fluorescence
detection.
J Chromatogr A
2008; 1209: 70-5.
38. Amon U, Bangha E, Kuster T, Menne A, Vollrath IB, Gibbs BF. Enteral
histaminosis: Clinical implications.
InflammRes
1999; 48: 291-5.
39. Horton JR, Sawada K, Nishibori M, Cheng X. Structural basis for
inhibition of histamine N-methyltransferase by diverse drugs.
J Mol Biol
2005; 353: 334-44.
40. Schwelberger HG. Diamine oxidase (DAO) enzyme and gene.
En Falus A, Grosman N, Darvas Z, eds. Histamine: biology and
medical aspects. Budapest, Springer Med Pub. 2004: 43-52.
41. Petersen J, Raithel M, Schwelberger HG. Characterization of
functional polymorphisms of the human diamine oxidase gene.
Inflamm Res
2005; 54 (Suppl.): S58-9.
42. Petersen J, Drasche A, Raithel M, Schwelberger HG. Analysis of
genetic polymorphisms of enzymes involved in histamine
metabolism.
Inflamm Res
2003; 52 (Suppl.): S69-70.
Monografías de
Dermatología
36